Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Marek Cierny MD

Marek Cierny MD profile photo picture

Adjunct Assistant Professor

Institution: Medical College of Wisconsin
Department: Neurology
Division: Hospitalist
Program: Hospitalist

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0002-3038-6405

Member of the Center for Advancing Population Science (CAPS)
Member of the Wisconsin Institute of NeuroScience (WINS)


I am willing to collaborate on research projects.
I am willing to mentor a junior faculty member.

View Curriculum Vitae

Publications (13)

  • Patient's understanding of and satisfaction with acute stroke treatment. (Vanguru HR, Čierny M, Blaginykh E, Handshoe LS, Uchino K) Clin Neurol Neurosurg 2024 Feb;237:108163 PMID: 38359521 SCOPUS ID: 2-s2.0-85185562794 02/16/2024    
  • Status Cataplecticus Induced by an Abrupt Duloxetine Withdrawal-A Case Report. (Cierny M, Feemster J, Hamid M, Battistini HA) Clin Neuropharmacol 2023 Sep-Oct 01;46(5):198-199 PMID: 37748003 SCOPUS ID: 2-s2.0-85172216275 09/25/2023    
  • Pearls & Oy-sters: Mitral Annular Calcification as a Cause of Ischemic Stroke: A Case Report. (Vishwanath R, Amin M, Cierny M, Tan C, Buletko AB) Neurology 2023 Aug 15;101(7):e777-e779 PMID: 36990722 PMCID: PMC10437025 SCOPUS ID: 2-s2.0-85168315812 03/30/2023    
  • Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. (Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F, REGAIN Study Group) Muscle Nerve 2021 Dec;64(6):662-669 PMID: 34590717 SCOPUS ID: 2-s2.0-85117104099 10/01/2021       9 Citations
  • Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension. (Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF Jr, REGAIN Study Group) Neurology 2021 Jan 26;96(4):e610-e618 PMID: 33229455 PMCID: PMC7905790 SCOPUS ID: 2-s2.0-85100445590 11/25/2020       44 Citations
  • Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome. (Čierny M, Hooshmand SI, Fee D, Tripathi S, Dsouza NR, La Pean Kirschner A, Zimmermann MT, Brennan R) Parkinsonism Relat Disord 2020 Aug;77:110-113 PMID: 32712562 SCOPUS ID: 2-s2.0-85088215494 07/28/2020       6 Citations
  • Consistent improvement with eculizumab across muscle groups in myasthenia gravis. (Mantegazza R, O'Brien FL, Yountz M, Howard JF Jr, REGAIN study group) Ann Clin Transl Neurol 2020 Aug;7(8):1327-1339 PMID: 32700461 PMCID: PMC7448154 SCOPUS ID: 2-s2.0-85088297453 07/24/2020       16 Citations
  • 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab. (Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF, REGAIN study group) J Neurol 2020 Jul;267(7):1991-2001 PMID: 32189108 PMCID: PMC7320935 SCOPUS ID: 2-s2.0-85085089028 03/20/2020       32 Citations
  • Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis. (Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr, REGAIN Study Group) Qual Life Res 2019 Aug;28(8):2255 PMID: 31115842 PMCID: PMC6620249 SCOPUS ID: 2-s2.0-85066885728 05/23/2019    
  • Eculizumab improves fatigue in refractory generalized myasthenia gravis. (Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr, REGAIN Study Group) Qual Life Res 2019 Aug;28(8):2247-2254 PMID: 30905021 PMCID: PMC6620379 SCOPUS ID: 2-s2.0-85065135150 03/25/2019       34 Citations
  • Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. (Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr, Regain Study Group) Muscle Nerve 2019 Jul;60(1):14-24 PMID: 30767274 PMCID: PMC6619057 SCOPUS ID: 2-s2.0-85062729927 02/16/2019       162 Citations
  • Tick-borne meningitis complicated by a cardioembolic intraluminal carotid artery thrombus and stroke (Čierny M, Škorňa M, Peška S, Polák P, Voháňka S) Ceska a Slovenska Neurologie a Neurochirurgie 2019;82(2):227-228 SCOPUS ID: 2-s2.0-85068980383 01/01/2019    
  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. (Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R, REGAIN Study Group) Lancet Neurol 2017 Dec;16(12):976-986 PMID: 29066163 SCOPUS ID: 2-s2.0-85035019720 10/27/2017       446 Citations
    • Last update: 02/29/2024